Innoviva, Inc. logo

Innoviva, Inc.

NASDAQ:INVA

Overview | Financials
Company Name Innoviva, Inc.
Symbol INVA
Currency USD
Price 20.09
Market Cap 1,261,153,768
Dividend Yield 0%
52-week-range 16.18 - 22
Industry Biotechnology
Sector Healthcare
CEO Mr. Pavel Raifeld C.F.A.
Website https://www.inva.com

An error occurred while fetching data.

About Innoviva, Inc.

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium

Related Stocks

Adaptive Biotechnologies Corporation logo

Adaptive Biotechnologies Corporation

ADPT

11.65 USD

SomaLogic, Inc. logo

SomaLogic, Inc.

SLGC

2.1 USD

Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc.

ALLO

1.13 USD

Instil Bio, Inc. logo

Instil Bio, Inc.

TIL

20.83 USD

NGM Biopharmaceuticals, Inc. logo

NGM Biopharmaceuticals, Inc.

NGM

1.54 USD

Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc.

AGIO

33.26 USD

RadNet, Inc. logo

RadNet, Inc.

RDNT

56.91 USD

Outset Medical, Inc. logo

Outset Medical, Inc.

OM

19.21 USD

Celularity Inc. logo

Celularity Inc.

CELU

1.96 USD

Financials

Numbers are in millions USD

Numbers are in millions USD